These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37256781)

  • 1. Survival of U.S. Military Service Members With Lymphoma.
    Ancira G; Romain J; Pham K; Thornton JA; DeStefano CB
    Mil Med; 2023 Nov; 188(11-12):e3407-e3410. PubMed ID: 37256781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caring for Service Members Who Have Been Sexually Assaulted: The Military Health System.
    Murray AL; Perez Koehlmoos T; Banaag A; Schvey NA
    Mil Med; 2023 Jul; 188(7-8):1609-1614. PubMed ID: 35751587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active Duty Service Members Newly Presenting With Low Back Pain in Fiscal Year 2017: Health Care Utilization, Access to Care, and Private Sector Costs Over 2-year Follow-up.
    Yuan X; Pav V; Colahan C; Miller ME; Hager NA; Pasquina PF; Cohen SP; Isaacson BM
    Mil Med; 2023 Jul; 188(7-8):e2387-e2396. PubMed ID: 36433751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of Behavioral Health Comorbidities on Outpatient Health Care Utilization by Active Duty Service Members With a First Documented mTBI.
    Kasuske LM; Hoover P; Wu T; French LM; Caban JJ
    Mil Med; 2021 Jan; 186(Suppl 1):567-571. PubMed ID: 33499506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK/T-cell lymphomas.
    Dubal PM; Dutta R; Vazquez A; Patel TD; Baredes S; Eloy JA
    Laryngoscope; 2015 May; 125(5):1077-83. PubMed ID: 25546466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health behavior profiles and association with mental health status among US active-duty service members.
    Olapeju B; Hendrickson ZM; Shanahan P; Mushtaq O; Ahmed AE
    Front Public Health; 2024; 12():1324663. PubMed ID: 38454988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Duty Service Members, Primary Managers, and Administrators' Perspectives on a Novel Sleep Telehealth Management Platform in the U.S. Military Healthcare System.
    Wickwire EM; Abdelwadoud M; Collen J; Edwards H; Labra C; Capaldi VF; Williams SG; Manber R; Assefa SZ; Drake CL; Albrecht JS; Bevan J; Mahoney A; Tatum ED; Pierre E; Mantua J; Grandner MA; Mullins CD
    Mil Med; 2022 Aug; 187(9-10):e1201-e1208. PubMed ID: 35089344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
    Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
    Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Outcomes for Advanced-Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
    Guru Murthy GS; Szabo A; Hamadani M; Fenske TS; Shah NN
    Oncologist; 2019 Nov; 24(11):1488-1495. PubMed ID: 31467178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
    Griffiths R; Gleeson M; Knopf K; Danese M
    BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors.
    Berkman AM; Andersen CR; Puthenpura V; Livingston JA; Ahmed S; Cuglievan B; Hildebrandt MAT; Roth ME
    Cancer Epidemiol; 2021 Dec; 75():102044. PubMed ID: 34597882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engaging Stakeholders to Optimize Sleep Disorders' Management in the U.S. Military: A Qualitative Analysis.
    Abdelwadoud M; Collen J; Edwards H; Mullins CD; Jobe SL; Labra C; Capaldi VF; Assefa SZ; Williams SG; Drake CL; Albrecht JS; Manber R; Mahoney A; Bevan J; Grandner MA; Wickwire EM
    Mil Med; 2022 Jul; 187(7-8):e941-e947. PubMed ID: 34424328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-Related Practices, Behaviors, and Sleep-Related Difficulties in Deployed Active-Duty Service Members Performing Security Duties.
    Matsangas P; Shattuck NL; Saitzyk A
    Behav Sleep Med; 2020; 18(2):262-274. PubMed ID: 30764663
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiologic, prognostic, and treatment factors in sinonasal diffuse large B -cell lymphoma.
    Varelas AN; Eggerstedt M; Ganti A; Tajudeen BA
    Laryngoscope; 2019 Jun; 129(6):1259-1264. PubMed ID: 30570148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
    Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
    Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
    Milano AF
    J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health and health behavior differences: U.S. Military, veteran, and civilian men.
    Hoerster KD; Lehavot K; Simpson T; McFall M; Reiber G; Nelson KM
    Am J Prev Med; 2012 Nov; 43(5):483-9. PubMed ID: 23079170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.
    Howlader N; Mariotto AB; Besson C; Suneja G; Robien K; Younes N; Engels EA
    Cancer; 2017 Sep; 123(17):3326-3334. PubMed ID: 28464214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
    Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
    Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.